Dr. Roman Perez-Soler

Dr. Roman Perez-Soler has dedicated his research work to developing novel ways to help patients with metastatic lung cancers, including mesothelioma. Worldwide, he is known as an expert in experimental cancer treatments and an inventor who is continually discovering new ways to help cancer patients.

Perez-Soler is on the leading edge of clinical trials that are aimed at curing lung cancers. He is the chairman of the oncology department, the deputy director of the Albert Einstein Cancer Center and the chief of the division of medical oncology at Montefiore Medical Center, the academic medical center and the university hospital for the Albert Einstein College of Medicine in New York City.

In the last 30 years, some of Perez-Soler’s accomplishments include pioneering new types of cancer treatments, clinical studies with growth factors and new interventions for patients who are at risk for developing lung cancer. He is an inventor with 17 patents and published more than 200 books and book chapters.

Specialists in New York City

From the city to the country, New York is known to have many locations where asbestos was widely used. Asbestos was used in buildings, shipyards, factories, chemical plants, power generators, schools and churches, just to name a few. In Upstate New York, there are several naturally occurring asbestos deposits, including a large one in Jefferson County. In the city, asbestos could be found in everything from shipyards to truck-body shops. On Long Island, it was used in new-home constructions.

If you or a family member has been exposed to asbestos in New York, contact us today for more information about a nearby mesothelioma expert. We will help you get quick access to one of the premiere experts in the world.

What are Perez-Soler’s specialties

Perez-Soler focuses his clinical work on the treatment of lung cancers, including mesothelioma. His research includes the drug delivery of anti-tumor agents and new treatments for lung cancer.

He is the founder of Aronex Pharmaceuticals and Transave, Inc, which work to create new medications for cancer treatments.

Perez-Soler is continually working to develop new medications that will slow tumor growth, limit the spread of the disease, reduce pain and extend the quality of life. With recent discoveries in targeted molecular therapies, Perez-Soler is looking for ways that cancer is treated and diagnosed.

Perez-Soler is a prolific author of academic papers to further the work towards more effective treatment and a possible cure. Some of his more recent work includes the treatment of non-small cell lung cancer with erlotinib or gefitnib.

What is Perez-Soler’s background

Perez-Soler received his medical degree from the Universidad Autonoma of Barcelona in Spain and finished his post-graduate training at MD Anderson Cancer Center in Texas. He went on to be a professor of medicine and the deputy chairman of the center’s department of thoracic, head and neck medical oncology. He joined New York University’s staff in 2001 as a professor and the chairman of the oncology department at Montefiore. He became the deputy director at the Albert Einstein Cancer Center in 2012.

Perez-Soler is a Fullbright Scholar and received MD Anderson’s Distinguished Alumnus Award. Since 1989, the National Cancer Institute has continually funded his research.